Drug-like inhibitor shows promise in preventing flu Scripps Research scientists have developed a potential drug-like molecule that blocks the first stage of type A influenza infection.
May 21, 2024
LA JOLLA, CA Currently available flu medications only target the virus after it has already established an infection, but what if a drug could prevent infection in the first place? Now, scientists at Scripps Research and the Albert Einstein College of Medicine have designed drug-like molecules to do just that, by thwarting the first stage of influenza infection.
The drug-like inhibitors block the virus from entering the body's respiratory cells specifically, they target hemagglutinin, a protein on the surface of type A influenza viruses. The findings, published in the Proceedings of the National Academy of Sciences on May 16, 2024, represent an important step forward in developing a drug that can prevent influenza infection.
We're trying to target the very first stage of influenza infection since it would be better to prevent infection in the first place, but these molecules could also be used to inhibit the spread of the virus after ones infected, says corresponding author Ian Wilson, DPhil, the Hansen Professor of Structural Biology at Scripps Research.
The inhibitors will need to be further optimized and tested before they can be assessed as antivirals in humans, but the researchers say that these molecules ultimately have the potential to help prevent and treat seasonal flu infections. And, unlike vaccines, the inhibitors likely wouldn't need to be updated yearly.
The researchers had previously identified a small molecule, F0045(S), with a limited capacity to bind and inhibit H1N1 type A influenza viruses.
We began by developing a high-throughput hemagglutinin binding assay that allowed us to rapidly screen large libraries of small molecules and found the lead compound F0045(S) with this process, says corresponding author Dennis Wolan, PhD, senior principal scientist at Genentech and former associate professor at Scripps Research.
In this study, the team aimed to optimize F0045(S)'s chemical structure to design molecules with better drug-like properties and more specific binding ability to the virus. To start, the Wolan lab used SuFEx click-chemistry, which was first developed by two-time Nobel laureate and co-author K. Barry Sharpless, PhD, to generate a large library of candidate molecules with various tweaks to F0045(S)'s original structure. When they screened this library, the researchers identified two molecules 4(R) and 6(R) with superior binding affinity compared to F0045(S).
Next, Wilson's lab produced X-ray crystal structures of 4(R) and 6(R) bound to the flu hemagglutinin protein so that they could identify the molecules' binding sites, determine the mechanisms behind their superior binding ability, and identify areas for improvement.
We showed that these inhibitors bind much more tightly to the viral antigen hemagglutinin than the original lead molecule did, says Wilson. By using click-chemistry, we basically extended the compounds' ability to interact with influenza by making them target additional pockets on the antigen surface.
When the researchers tested 4(R) and 6(R) in cell culture to verify their antiviral properties and safety, they found 6(R) was non-toxic and had more than 200-times improved cellular antiviral potency compared to F0045(S).
Finally, the researchers used a targeted approach to further optimize 6(R) and develop compound 7, which proved to have even better antiviral ability.
This is the most potent small-molecule hemagglutinin inhibitor developed to date, says corresponding author Seiya Kitamura, who worked on the project as a postdoctoral fellow at Scripps Research and is now an assistant professor at the Albert Einstein College of Medicine.
In future studies, the team plans to continue to optimize compound 7 and to test the inhibitor in animal models of influenza.
In terms of potency, it will be hard to improve the molecule any further, but there are many other properties to consider and optimize, for example, pharmacokinetics, metabolism and aqueous solubility, says Kitamura.
Because the inhibitors developed in this study only target H1N1 strains of influenza, researchers are also working to develop equivalent drug-like inhibitors to target other strains of influenza such as H3N2 and H5N1.
In addition to Wilson, Wolan, Sharpless, and Kitamura, authors of the study, Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry include Ting-Hui Lin, Chang-Chun David Lee, Akihiro Takamura, Rameshwar Kadam, Ding Zhang, Xueyong Zhu, Wenli Yu, and Yao Yao of Scripps Research; and Lucas Dada, Emiko Nagai of Albert Einstein College of Medicine
This work was supported by the NIH, the Nathan Shock Institute of Aging Research, and Einstein- Montefiore.
Infectious Diseases Integrative Structural & Computational Biology Wilson, Ian Wilson
Most recent headlines
09/11/2025
Dalet today announced a transformative leap forward for media operations: Agentic Artificial Intelligence (AI) that unifies the Dalet ecosystem under one natura...
15/10/2025
One of humanity's most profound questions continues: Is there any place in our galaxy suitable for life beyond Earth? NASA intends to find out, with the hel...
15/10/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
15/10/2025
Scality, a global leader in cyber-resilient storage software for the AI era, today announced the advancement of its comprehensive AI ecosystem certification pro...
15/10/2025
The Hollywood Professional Association (HPA) today unveiled key highlights of the 2026 HPA Tech Retreat, scheduled for Feb. 15 19 at the Westin Rancho Mirage Go...
15/10/2025
At NAB Show New York 2025 (Stand 244), Interra Systems will showcase the future of media QC, monitoring, and captioning, highlighting its award-winning, AI- and...
15/10/2025
Grass Valley today announced that RMC BFM, part of the CMA-CGM Group and France's third-largest private media group, has chosen Grass Valley's productio...
15/10/2025
Appear, the global leader in live production technology, will demonstrate how its powerful hardware and software innovations are shaping the future of hybrid, s...
15/10/2025
Rakim to Join Berklee's Hip-Hop Hall of Fame at Signature Series Concert The rap icon becomes the latest inductee, following luminaries such as Roxanne Sh...
15/10/2025
Berklee Brings Live Music to the Head of the Charles Student artists will perform on multiple riverfront stages during the 60th anniversary of the world's...
15/10/2025
CobbTV, the government access television channel for Cobb County, Ga. recently acquired an automated playout system from Pebble, a global provider of automation...
15/10/2025
OSLO, Norway Appear, the global leader in live production technology, will demonstrate how its powerful hardware and software innovations are shaping the future...
15/10/2025
NEW YORK The NBA is making major changes to the NBA App and NBA TV as it takes control of them from TNT Sports, which has long managed the league's digital ...
15/10/2025
SAN MATEO, Calif. In what promises to be a major expansion of interactive features and personalized content on the DirecTV platform, the operator and Glance hav...
15/10/2025
SAN JOSE, Calif. Roku has launched changes to its user interface (UI) that the streaming platform says will better showcase original programming on the platform...
15/10/2025
LOS ANGELES Software-defined data storage and data services provider OpenDrives has elevated Alex Dunfey to chief technology officer, responsible for driving th...
15/10/2025
Back to All News
Revenge Series The Resurrected' Captivates Audiences Across Asia
Entertainment
15 October 2025
GlobalTaiwan
Link copied to clipboard
...
15/10/2025
Back to All News
Bringing the Best in VFX and Virtual Production Together as Eyeline
Jeffrey Shapiro
CEO, Eyeline
Business
15 October 2025
GlobalCanadaInd...
15/10/2025
Deployed by Astound Business Solutions, Harmonic's Primary Distribution Solution Ensures Outstanding Video Quality and Seamless Ad Insertion at the Edge
SA...
15/10/2025
Collaboration extends a trusted relationship as RMC BFM invests in scalable, fut...
15/10/2025
Series coming in 2026 stars Tom Vaughan-Lawlor, Justine Mitchell and Jason O'Mara released today
RT today released first look images of new comedy-drama ...
14/10/2025
SVG Europe Summit 2025: All Sessions Now Available to Watch on SVG PLAYNetworking event that preceded IBC2025 shone a light on elite live sports innovation acro...
14/10/2025
SVG Sit-Down: Author Rich Podolsky on Writing Madden & Summerall: How They Revo...
14/10/2025
SVG All-Stars: Michael Reiners, Coordinating Producer, FloRacingThe Illinois State grad steers a vast schedule of motorsports events at tracks across the countr...
14/10/2025
Content protection: Getting the right management for your DRM By Neal Romanek
Friday, October 10, 2025 - 10:11
Print This Story
Eluvio power the EPCR'...
14/10/2025
As League Takes Over Ops, NBA TV and NBA App Add 60 Games, Weekday Studio Show, ...
14/10/2025
Time and effort: World's largest student-led broadcast prepares to go On Air...
14/10/2025
(L-R) Guest, Kimberly Robinson Jones, Geeta Gandbhir, Pamela Dias, and Takema Ro...
14/10/2025
Lossless ist jetzt mit Spotify Premium verf gbar.
Verlustfreies Audio war eine...
14/10/2025
La qualit Lossless est disponible sur Spotify Premium.
Le format sans perte de...
14/10/2025
For the seventh edition of Spotify and FC Barcelona's artist jersey series, ...
14/10/2025
Spotify is committed to bringing the best listening experience to all our users, and that includes parents and families. That's why we're expanding mana...
14/10/2025
Since its debut, the Spotify Original podcast Caso 63 has been more than just a story; it's been a cultural sensation. The science fiction thriller captivat...
14/10/2025
Desde su debut, el podcast original de Spotify Caso 63 ha sido mucho m s que una historia: se ha convertido en un fen meno cultural. Este thriller de ciencia fi...
14/10/2025
Lossless p Spotify Premium r h r.
Lossless-ljud har varit en av de mest efterl ngtade funktionerna p Spotify och nu, ntligen, har den b rjat rullas ut til...
14/10/2025
Early next year, your favorite video podcasts are getting a bigger stage. Spotify and Netflix are teaming up to bring sports, culture, lifestyle, and true crime...
14/10/2025
Last week, the 4th global Safety Day took place at all SGL Carbon sites.
This years Safety Day focused on hazardous substances. Various information events, wor...
14/10/2025
From bowser to basket, 9 in 10 Aussies are feeling the impact of rising prices
26% of households earn over $160k, but are still concerned about rising prices...
14/10/2025
New players take a bite out of big bank share as consumers increasingly value tr...
14/10/2025
56% of Aussies are looking for a coastal holiday, while 40% are planning a road ...
14/10/2025
51% of Aussies want a hybrid car and 36% want a full EV
Toyota leads the market
75% research online before a new car purchase
Sydney - October 14, 2025 - Aus...
14/10/2025
Unilever leads the market
Beverages, smartphones, and food dominate category sp...
14/10/2025
Top insurance advertisers
Biggest growth categories
Sector ad spend up 4.7...
14/10/2025
WAYNE, Pa. Private-equity firm Saothair Capital Partners said it has completed the acquisition of GatesAir through a newly-formed affiliate....
14/10/2025
Media Excel, a leading provider of encoding and transcoding solutions, today announced that Space Norway, a leading provider of satellite services and operator ...
14/10/2025
Jason Tyler has joined ZTransform, a leader in media environment innovation, as Inside Sales and Procurement Manager bringing commercial and operational focus t...
14/10/2025
14 10 2025 - Media release Tiny toys, big missions: Knee High Spies launches on ABC this November
Knee High Spies
Kids, assemble! The ABC and Screen Australi...
14/10/2025
Abu Dhabi, UAE October 14, 2025: Space42 (ADX: SPACE42), the AI-powered SpaceT...
14/10/2025
Abu Dhabi, UAE October 14, 2025: Space42 (ADX: SPACE42), the UAE-based AI-powered SpaceTech company with a global reach, has signed a Memorandum of Understand...
Drug-like inhibitor shows promise in preventing flu Scripps Research scientists have developed a potential drug-like molecule that blocks the first stage of type A influenza infection.
